Comparative Effectiveness Research to Enhance Outcomes in African-Americans With Obstructive Sleep Apnea
2 other identifiers
interventional
75
1 country
1
Brief Summary
Obstructive Sleep Apnea (OSA) is under-diagnosed and is associated with increased cardiovascular morbidity and mortality. Laboratory-based overnight polysomnography (PSG) is the gold standard in clinical practice to diagnose OSA but has availability, cost, and resource limitations. In the last decade, an alternative diagnostic strategy, Portable Monitoring (PM) has emerged with the goal of reducing expense and delays in clinical management. In contrast to PSG, PM maybe performed unattended in homes, utilize different neurophysiologic and cardiorespiratory parameters, and may synthesize these data differently. PM is feasible and is approved by Centers for Medicare and Medicaid Services (CMS) in the United States. However, the diagnostic utility of PM in minority and underserved populations is not defined. African-Americans are more severely affected by hypertension and cardiovascular disease (CVD) than other ethnic groups and OSA is more common in this population. OSA is a treatable cause of hypertension. Despite this the impact of timely interventions for OSA on health outcomes and risk reduction specific to African Americans is unknown. Purpose of this research: In view of the vulnerability of this population and the potential for improvement in healthcare access for OSA with home-based diagnosis, this study aims to establish the feasibility and identify the potential advantages and limitations of home-based diagnosis of OSA in a high-risk urban African-American population including veterans with frequently limited access to healthcare. Hypothesis: The investigators hypothesize that home-based PM is not inferior to standard laboratory-based PSG in effectively diagnosing OSA in urban African Americans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 22, 2013
CompletedFirst Posted
Study publicly available on registry
November 28, 2013
CompletedResults Posted
Study results publicly available
June 20, 2014
CompletedMay 29, 2024
May 1, 2024
8 months
November 22, 2013
December 9, 2013
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apnea Hypopnea Index (AHI)
AHI is the number of abnormal respiratory events (apneas and hypopneas) per hour of sleep. AHI on home portable monitor (PM) compared to AHI on laboratory polysomnography (PSG).
4 days
Secondary Outcomes (1)
Technical Failure Rate
4 days
Other Outcomes (1)
Percentage of Participants Who Prefer Home Testing Over Laboratory Testing
1 week
Study Arms (1)
OSA testing
EXPERIMENTALCross-over design, single group/arm Interventions: polysomnography with simultaneous portable monitoring and home portable monitoring administered to each participant in random order.
Interventions
A device applied over 1 arm (on the wrist and finger), worn overnight by patients to detect OSA.
Portable monitoring with WP200 device - applied by participants once at home.
Portable monitoring with WP200 device - applied by technologist once in the laboratory simultaneously with polysomnography.
Eligibility Criteria
You may qualify if:
- Male and Female African-Americans (age ≥18 years)
- Berlin Questionnaire
- Ability to understand written and verbal English
You may not qualify if:
- Past treatment of OSA (medical, dental, or surgical)
- Other primary sleep disorder(s) by history
- Active uncontrolled medical conditions/immobility
- Current drug or significant alcohol use
- No current residential address or contact phone number
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Illinois at Chicagolead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Sleep Science Center
Chicago, Illinois, 60612, United States
Related Publications (1)
Garg N, Rolle AJ, Lee TA, Prasad B. Home-based diagnosis of obstructive sleep apnea in an urban population. J Clin Sleep Med. 2014 Aug 15;10(8):879-85. doi: 10.5664/jcsm.3960.
PMID: 25126034DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This trial did not compare different portable devices for diagnostic accuracy compared to polysomnography (gold standard).
Results Point of Contact
- Title
- Bharati Prasad
- Organization
- UIllinois
Study Officials
- PRINCIPAL INVESTIGATOR
Bharati Prasad, MD
University of Illinois at Chicago
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 22, 2013
First Posted
November 28, 2013
Study Start
August 1, 2011
Primary Completion
April 1, 2012
Study Completion
April 1, 2013
Last Updated
May 29, 2024
Results First Posted
June 20, 2014
Record last verified: 2024-05